US Bancorp’s Aratana Therapeutics, Inc. PETX Stock Holding History
Bought
Maintained
Sold
Other funds holding PETX
BC
AIC
US Bancorp's PETX Position: Q2 2017 in Review
US Bancorp sold out of Aratana Therapeutics, Inc. (PETX) in Q2 2017, closing a stake of 200 shares — an estimated $1K sold.
US Bancorp first reported a position in PETX in Q1 2014 and held it in 8 quarters. The position peaked at $40K in Q1 2014. 105 funds tracked by Wall St. Rank hold PETX as of Q2 2017.
- US Bancorp reported no remaining Aratana Therapeutics, Inc. position as of Q2 2017 after selling out during the quarter.
- US Bancorp sold 200 Aratana Therapeutics, Inc. shares in Q2 2017, an estimated $1K.
- US Bancorp first reported a position in Aratana Therapeutics, Inc. in Q1 2014 and held it in 8 quarters.
- US Bancorp's Aratana Therapeutics, Inc. position peaked at $40K in Q1 2014.
- 105 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q2 2017.
Based on US Bancorp's 13F filing for Q2 2017, filed 20 Jul 2017.